Cargando…

Investigating hospital heterogeneity with a competing risks frailty model

Survival analysis is used in the medical field to identify the effect of predictive variables on time to a specific event. Generally, not all variation of survival time can be explained by observed covariates. The effect of unobserved variables on the risk of a patient is called frailty. In multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rueten‐Budde, Anja J., Putter, Hein, Fiocco, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587741/
https://www.ncbi.nlm.nih.gov/pubmed/30338563
http://dx.doi.org/10.1002/sim.8002
_version_ 1783429128112832512
author Rueten‐Budde, Anja J.
Putter, Hein
Fiocco, Marta
author_facet Rueten‐Budde, Anja J.
Putter, Hein
Fiocco, Marta
author_sort Rueten‐Budde, Anja J.
collection PubMed
description Survival analysis is used in the medical field to identify the effect of predictive variables on time to a specific event. Generally, not all variation of survival time can be explained by observed covariates. The effect of unobserved variables on the risk of a patient is called frailty. In multicenter studies, the unobserved center effect can induce frailty on its patients, which can lead to selection bias over time when ignored. For this reason, it is common practice in multicenter studies to include a random frailty term modeling center effect. In a more complex event structure, more than one type of event is possible. Independent frailty variables representing center effect can be incorporated in the model for each competing event. However, in the medical context, events representing disease progression are likely related and correlation is missed when assuming frailties to be independent. In this work, an additive gamma frailty model to account for correlation between frailties in a competing risks model is proposed, to model frailties at center level. Correlation indicates a common center effect on both events and measures how closely the risks are related. Estimation of the model using the expectation‐maximization algorithm is illustrated. The model is applied to a data set from a multicenter clinical trial on breast cancer from the European Organisation for Research and Treatment of Cancer (EORTC trial 10854). Hospitals are compared by employing empirical Bayes estimates methodology together with corresponding confidence intervals.
format Online
Article
Text
id pubmed-6587741
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65877412019-07-02 Investigating hospital heterogeneity with a competing risks frailty model Rueten‐Budde, Anja J. Putter, Hein Fiocco, Marta Stat Med Research Articles Survival analysis is used in the medical field to identify the effect of predictive variables on time to a specific event. Generally, not all variation of survival time can be explained by observed covariates. The effect of unobserved variables on the risk of a patient is called frailty. In multicenter studies, the unobserved center effect can induce frailty on its patients, which can lead to selection bias over time when ignored. For this reason, it is common practice in multicenter studies to include a random frailty term modeling center effect. In a more complex event structure, more than one type of event is possible. Independent frailty variables representing center effect can be incorporated in the model for each competing event. However, in the medical context, events representing disease progression are likely related and correlation is missed when assuming frailties to be independent. In this work, an additive gamma frailty model to account for correlation between frailties in a competing risks model is proposed, to model frailties at center level. Correlation indicates a common center effect on both events and measures how closely the risks are related. Estimation of the model using the expectation‐maximization algorithm is illustrated. The model is applied to a data set from a multicenter clinical trial on breast cancer from the European Organisation for Research and Treatment of Cancer (EORTC trial 10854). Hospitals are compared by employing empirical Bayes estimates methodology together with corresponding confidence intervals. John Wiley and Sons Inc. 2018-10-18 2019-01-30 /pmc/articles/PMC6587741/ /pubmed/30338563 http://dx.doi.org/10.1002/sim.8002 Text en © 2018 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Rueten‐Budde, Anja J.
Putter, Hein
Fiocco, Marta
Investigating hospital heterogeneity with a competing risks frailty model
title Investigating hospital heterogeneity with a competing risks frailty model
title_full Investigating hospital heterogeneity with a competing risks frailty model
title_fullStr Investigating hospital heterogeneity with a competing risks frailty model
title_full_unstemmed Investigating hospital heterogeneity with a competing risks frailty model
title_short Investigating hospital heterogeneity with a competing risks frailty model
title_sort investigating hospital heterogeneity with a competing risks frailty model
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587741/
https://www.ncbi.nlm.nih.gov/pubmed/30338563
http://dx.doi.org/10.1002/sim.8002
work_keys_str_mv AT ruetenbuddeanjaj investigatinghospitalheterogeneitywithacompetingrisksfrailtymodel
AT putterhein investigatinghospitalheterogeneitywithacompetingrisksfrailtymodel
AT fioccomarta investigatinghospitalheterogeneitywithacompetingrisksfrailtymodel